Lau, T. S., Lau, T. S., Lau, T. S., Bossen, L., Bossen, L., Rasmussen, D. G. K., . . . Dam, G. (2025). Fibrosis markers as prognostic markers of decline in kidney function in patients with neuroendocrine neoplasms undergoing peptide receptor radionuclide therapy. Frontiers Media S.A.
Chicago Style (17th ed.) CitationLau, Tobias Stemann, et al. Fibrosis Markers as Prognostic Markers of Decline in Kidney Function in Patients with Neuroendocrine Neoplasms Undergoing Peptide Receptor Radionuclide Therapy. Frontiers Media S.A, 2025.
MLA (9th ed.) CitationLau, Tobias Stemann, et al. Fibrosis Markers as Prognostic Markers of Decline in Kidney Function in Patients with Neuroendocrine Neoplasms Undergoing Peptide Receptor Radionuclide Therapy. Frontiers Media S.A, 2025.
Warning: These citations may not always be 100% accurate.